Peptide stacks · Weight and metabolism

5-Amino-1MQ and retatrutide stack: what’s in it and the evidence

Checked against our library and study pagesPublished by PepVault

The 5-Amino-1MQ and retatrutide stack is two compounds run side by side, each from its own vial or form: 5-Amino-1MQ and retatrutide. The library records 5-Amino-1MQ at 50–100 mg and retatrutide at 1–12 mg per dose as reference ranges.

This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.

What’s in the 5-Amino-1MQ and retatrutide stack

The two parts of the 5-Amino-1MQ and retatrutide stack
PartReference rangeFiled underEvidence (library)
5-Amino-1MQ50–100 mgFat metabolism, NAD+ boost, Lean mass preservationEmerging
Retatrutide1–12 mgTriple-agonist, Highest weight loss, Energy expenditureEstablished

The library’s reference range per dose, part by part

  • 5-Amino-1MQ50–100 mg

  • Retatrutide1–12 mg

Each bar runs from the low to the high end of what the library records for each part of the 5-Amino-1MQ and retatrutide stack, on one scale.

5-Amino-1MQ

5-Amino-1MQ is one of the two parts of the 5-Amino-1MQ and retatrutide stack. A small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, which raises NAD+ and pushes fat cells toward burning energy.

Retatrutide

Retatrutide is one of the two parts of the 5-Amino-1MQ and retatrutide stack. The first triple agonist to reach phase 3: it activates GLP-1, GIP and glucagon receptors at once, and the glucagon arm adds extra calorie burn (shown in mice).

A smiling woman in a dark training top in her kitchen, holding a glass of water

Model. Individual results vary.

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Has the 5-Amino-1MQ and retatrutide stack been studied as a combination?

None of our 436 study pages tested 5-Amino-1MQ and retatrutide together, so the 5-Amino-1MQ and retatrutide stack rests on studies of its parts and on community reports.

The studies of the parts, one by one: 3 study pages on 5-Amino-1MQ (0 in people) and 16 study pages on retatrutide (12 in people).

What people commonly report on the 5-Amino-1MQ and retatrutide stack

The library holds no report of what people notice on the 5-Amino-1MQ and retatrutide stack as a pair. What it records for each part on its own:

  • 5-Amino-1MQ: nothing to feel, though some describe easier fat loss alongside a deficit or a GLP-1.
  • Retatrutide: appetite suppression even stronger than tirzepatide, GI side effects after each step-up, and a higher resting heart rate.

These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.

Why these are combined

“5-Amino-1MQ + Retatrutide target intake and fat metabolism”, the library’s note on the pair (community report)

5-Amino-1MQ inhibits NNMT (an enzyme that, when overactive, slows fat metabolism); Retatrutide cuts appetite and intake.

How the parts of the 5-Amino-1MQ and retatrutide stack are mixed and taken

The 5-Amino-1MQ and retatrutide stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.

How each part of the 5-Amino-1MQ and retatrutide stack is taken, from its library entry
PartRouteHow oftenOur vial pages
5-Amino-1MQOralDailyNo vial page
RetatrutideSubQ injectionWeekly5 mg vial, 10 mg vial, 15 mg vial, 20 mg vial, 24 mg vial, 30 mg vial, 40 mg vial, 60 mg vial

Our vial pages work out the mix for each part’s own vial, size by size:

Compared with running the parts apart

The library’s notes on the 5-Amino-1MQ and retatrutide stack don’t compare it with running either part on its own.

Safety notes

The library holds no combination safety note on the 5-Amino-1MQ and retatrutide stack, so each part’s own notes apply, on its compound page.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Questions people ask

What is in the 5-Amino-1MQ and retatrutide stack?

The 5-Amino-1MQ and retatrutide stack is two compounds run side by side, each from its own vial or form: 5-Amino-1MQ and retatrutide. The library records 5-Amino-1MQ at 50–100 mg and retatrutide at 1–12 mg per dose as reference ranges.

Has the 5-Amino-1MQ and retatrutide stack been studied together?

Not as a combination in any of our study pages: the 5-Amino-1MQ and retatrutide stack rests on studies of its parts and on community reports.

Do the parts of the 5-Amino-1MQ and retatrutide stack come in one vial?

No: in the library each part of the 5-Amino-1MQ and retatrutide stack is its own compound with its own route and schedule (5-Amino-1MQ by Oral and retatrutide by SubQ injection).

What does each part of the 5-Amino-1MQ and retatrutide stack do?

5-Amino-1MQ: A small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, which raises NAD+ and pushes fat cells toward burning energy. Retatrutide: The first triple agonist to reach phase 3: it activates GLP-1, GIP and glucagon receptors at once, and the glucagon arm adds extra calorie burn (shown in mice).

More on these compounds

Track it in the app

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo